{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:28:09Z","timestamp":1755797289958,"version":"3.44.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ40739"],"award-info":[{"award-number":["2022JJ40739"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14718-4","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:54:45Z","timestamp":1755496485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Leveraging diverse liquid\u2013liquid phase separation patterns to predict the prognosis and immunotherapy of pediatric acute myeloid leukemia"],"prefix":"10.1186","volume":"25","author":[{"given":"Min","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yezhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijuan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuocheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"14718_CR1","doi-asserted-by":"publisher","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ (Clinical research ed.), 2021;375, n2026. https:\/\/doi.org\/10.1136\/bmj.n2026.","DOI":"10.1136\/bmj.n"},{"key":"14718_CR2","doi-asserted-by":"publisher","unstructured":"Creutzig U, van den Heuvel-Eibrink MM, Gibson B, Dworzak MN, Adachi S, de Bont E, Harbott J, Hasle H, Johnston D, Kinoshita A, Lehrnbecher T, Leverger G, Mejstrikova E, Meshinchi S, Pession A, Raimondi SC, Sung L, Stary J, Zwaan CM, Kaspers GJ, AML Committee of the International BFM Study Group. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood. 2012;120(16): 3187\u20133205. https:\/\/doi.org\/10.1182\/blood-2012-03-362608","DOI":"10.1182\/blood-2012-03-362608"},{"issue":"3","key":"14718_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/jcm11030504","volume":"11","author":"D Reinhardt","year":"2022","unstructured":"Reinhardt D, Antoniou E, Waack K. Pediatric acute myeloid Leukemia-Past, present, and future. J Clin Med. 2022;11(3):504. https:\/\/doi.org\/10.3390\/jcm11030504.","journal-title":"J Clin Med"},{"issue":"2","key":"14718_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Jabbour E, Garcia-Manero G, Konopleva M, Ravandi F. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11(2):41. https:\/\/doi.org\/10.1038\/s41408-021-00425-3.","journal-title":"Blood Cancer J"},{"issue":"4","key":"14718_CR5","first-page":"328","volume":"11","author":"FA Lagunas-Rangel","year":"2017","unstructured":"Lagunas-Rangel FA, Ch\u00e1vez-Valencia V, G\u00f3mez-Guijosa M\u00c1, Cortes-Penagos C. Acute myeloid Leukemia-Genetic alterations and their clinical prognosis. Int J hematology-oncology Stem Cell Res. 2017;11(4):328\u201339.","journal-title":"Int J hematology-oncology Stem Cell Res"},{"issue":"3","key":"14718_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2018.12.035","volume":"176","author":"S Alberti","year":"2019","unstructured":"Alberti S, Gladfelter A, Mittag T. Considerations and challenges in studying Liquid-Liquid phase separation and biomolecular condensates. Cell. 2019;176(3):419\u201334. https:\/\/doi.org\/10.1016\/j.cell.2018.12.035.","journal-title":"Cell"},{"key":"14718_CR7","doi-asserted-by":"publisher","unstructured":"Li RH, Tian T, Ge QW, He XY, Shi CY, Li JH, Zhang Z, Liu FZ, Sang LJ, Yang ZZ, Liu YZ, Xiong Y, Yan Q, Li X, Ju HQ, Liu J, Wang LJ, Shao JZ, Wang W, Zhou T, Lin A. A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid-liquid phase separation to promote oncogenic YAP signaling. Cell Res. 2021;31(10):1088\u20131105. https:\/\/doi.org\/10.1038\/s41422-021-00530-9","DOI":"10.1038\/s41422-021-00530-9"},{"key":"14718_CR8","doi-asserted-by":"publisher","unstructured":"Du M, Chen ZJ. DNA-induced liquid phase condensation of cGAS activates innate immune signaling. Science (New York). 2018;361:704\u20139. 6403https:\/\/doi.org\/10.1126\/science.aat1022.","DOI":"10.1126\/science.aat1022"},{"issue":"7","key":"14718_CR9","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.cell.2018.11.034","volume":"175","author":"S Hahn","year":"2018","unstructured":"Hahn S. Phase separation, protein disorder, and enhancer function. Cell. 2018;175(7):1723\u20135. https:\/\/doi.org\/10.1016\/j.cell.2018.11.034.","journal-title":"Cell"},{"issue":"7765","key":"14718_CR10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-019-1374-1","volume":"571","author":"RJ Ries","year":"2019","unstructured":"Ries RJ, Zaccara S, Klein P, Olarerin-George A, Namkoong S, Pickering BF, Patil DP, Kwak H, Lee JH, Jaffrey SR. m6A enhances the phase separation potential of mRNA. Nature. 2019;571(7765):424\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1374-1.","journal-title":"Nature"},{"key":"14718_CR11","doi-asserted-by":"publisher","first-page":"631486","DOI":"10.3389\/fcell.2021.631486","volume":"9","author":"J Lu","year":"2021","unstructured":"Lu J, Qian J, Xu Z, Yin S, Zhou L, Zheng S, Zhang W. Emerging roles of Liquid-Liquid phase separation in cancer: from protein aggregation to Immune-Associated signaling. Front Cell Dev Biology. 2021;9:631486. https:\/\/doi.org\/10.3389\/fcell.2021.631486.","journal-title":"Front Cell Dev Biology"},{"issue":"1","key":"14718_CR12","doi-asserted-by":"publisher","first-page":"e24135","DOI":"10.1002\/jcla.24135","volume":"36","author":"L Zhuge","year":"2022","unstructured":"Zhuge L, Zhang K, Zhang Z, Guo W, Li Y, Bao Q. A novel model based on liquid-liquid phase separation-Related genes correlates immune microenvironment profiles and predicts prognosis of lung squamous cell carcinoma. J Clin Lab Anal. 2022;36(1):e24135. https:\/\/doi.org\/10.1002\/jcla.24135.","journal-title":"J Clin Lab Anal"},{"key":"14718_CR13","doi-asserted-by":"publisher","unstructured":"Jiang F, Wang XY, Wang MY, Mao Y, Miao XL, Wu CY, Zhou GP. An immune checkpoint-related gene signature for predicting survival of pediatric acute myeloid leukemia. J Oncol. 2021;2021(5550116). https:\/\/doi.org\/10.1155\/2021\/5550116.","DOI":"10.1155\/2021\/5550116"},{"key":"14718_CR14","doi-asserted-by":"publisher","first-page":"1109518","DOI":"10.3389\/fonc.2023.1109518","volume":"13","author":"S Chaudhary","year":"2023","unstructured":"Chaudhary S, Ganguly S, Palanichamy JK, Singh A, Pradhan D, Bakhshi R, Chopra A, Bakhshi S. Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients. Front Oncol. 2023;13:1109518. https:\/\/doi.org\/10.3389\/fonc.2023.1109518.","journal-title":"Front Oncol"},{"key":"14718_CR15","doi-asserted-by":"publisher","first-page":"954524","DOI":"10.3389\/fmolb.2022.954524","volume":"9","author":"Y Tao","year":"2022","unstructured":"Tao Y, Wei L, You H. Ferroptosis-related gene signature predicts the clinical outcome in pediatric acute myeloid leukemia patients and refines the 2017 ELN classification system. Front Mol Biosci. 2022;9:954524. https:\/\/doi.org\/10.3389\/fmolb.2022.954524.","journal-title":"Front Mol Biosci"},{"key":"14718_CR16","doi-asserted-by":"publisher","first-page":"D354","DOI":"10.1093\/nar\/gkz847","volume":"48","author":"K You","year":"2020","unstructured":"You K, Huang Q, Yu C, Shen B, Sevilla C, Shi M, Hermjakob H, Chen Y, Li T. PhaSepDB: a database of liquid-liquid phase separation related proteins. Nucleic Acids Res. 2020;48:D354\u20139. https:\/\/doi.org\/10.1093\/nar\/gkz847.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"14718_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/bioinformatics\/btab561","volume":"38","author":"S Wang","year":"2022","unstructured":"Wang S, Xiong Y, Zhao L, Gu K, Li Y, Zhao F, Li J, Wang M, Wang H, Tao Z, Wu T, Zheng Y, Li X, Liu XS. UCSCXenaShiny: an R\/CRAN package for interactive analysis of UCSC Xena data. Bioinf (Oxford England). 2022;38(2):527\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btab561.","journal-title":"Bioinf (Oxford England)"},{"issue":"9","key":"14718_CR18","first-page":"6210","volume":"14","author":"Z Liu","year":"2022","unstructured":"Liu Z, Elcheva I. A six-gene prognostic signature for both adult and pediatric acute myeloid leukemia identified with machine learning. Am J Transl Res. 2022;14(9):6210\u201321. https:\/\/pubmed.ncbi.nlm.nih.gov\/36247279.","journal-title":"Am J Transl Res"},{"issue":"36","key":"14718_CR19","doi-asserted-by":"publisher","first-page":"39098","DOI":"10.18632\/oncotarget.5390","volume":"6","author":"MK Chuang","year":"2015","unstructured":"Chuang MK, Chiu YC, Chou WC, Hou HA, Tseng MH, Kuo YY, Chen Y, Chuang EY, Tien HF. An mRNA expression signature for prognostication in de Novo acute myeloid leukemia patients with normal karyotype. Oncotarget. 2015;6(36):39098\u2013110. https:\/\/doi.org\/10.18632\/oncotarget.5390.","journal-title":"Oncotarget"},{"issue":"1","key":"14718_CR20","doi-asserted-by":"publisher","first-page":"8079","DOI":"10.1038\/s41598-020-64929-x","volume":"10","author":"M Caron","year":"2020","unstructured":"Caron M, St-Onge P, Sontag T, Wang YC, Richer C, Ragoussis I, Sinnett D, Bourque G. Single-cell analysis of childhood leukemia reveals a link between developmental States and ribosomal protein expression as a source of intra-individual heterogeneity. Sci Rep. 2020;10(1):8079. https:\/\/doi.org\/10.1038\/s41598-020-64929-x.","journal-title":"Sci Rep"},{"key":"14718_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-1-0716-1307-8_19","volume":"2284","author":"S Slovin","year":"2021","unstructured":"Slovin S, Carissimo A, Panariello F, Grimaldi A, Bouch\u00e9 V, Gambardella G, Cacchiarelli D. Single-Cell RNA sequencing analysis: A Step-by-Step overview. Methods Mol Biology (Clifton N J). 2021;2284:343\u201365. https:\/\/doi.org\/10.1007\/978-1-0716-1307-8_19.","journal-title":"Methods Mol Biology (Clifton N J)"},{"issue":"16","key":"14718_CR22","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1002\/cam4.3240","volume":"9","author":"S Sun","year":"2020","unstructured":"Sun S, Guo W, Wang Z, Wang X, Zhang G, Zhang H, Li R, Gao Y, Qiu B, Tan F, Gao Y, Xue Q, Gao S, He J. Development and validation of an immune-related prognostic signature in lung adenocarcinoma. Cancer Med. 2020;9(16):5960\u201375. https:\/\/doi.org\/10.1002\/cam4.3240.","journal-title":"Cancer Med"},{"key":"14718_CR23","doi-asserted-by":"publisher","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA, Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol (Clifton, N.J.). 2018:1711;243\u2013259. https:\/\/doi.org\/10.1007\/978-1-4939-7493-1_12","DOI":"10.1007\/978-1-4939-7493-1_12"},{"issue":"6","key":"14718_CR24","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6):bbab260. https:\/\/doi.org\/10.1093\/bib\/bbab260.","journal-title":"Brief Bioinform"},{"issue":"1","key":"14718_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12885-025-13439-y","volume":"25","author":"D Wen","year":"2025","unstructured":"Wen D, Yan R, Zhang L, Zhang H, Chen X, Zhou J. Screening of necroptosis-related genes and evaluating the prognostic capacity, clinical value, and the effect of their copy number variations in acute myeloid leukemia. BMC Cancer. 2025;25(1):71. https:\/\/doi.org\/10.1186\/s12885-025-13439-y.","journal-title":"BMC Cancer"},{"issue":"12","key":"14718_CR26","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1007\/s00277-024-06119-7","volume":"103","author":"T Bin","year":"2024","unstructured":"Bin T, Tang J, Lu B, Xu XJ, Lin C, Wang Y. Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on golgi- associated genes. Ann Hematol. 2024;103(12):5297\u2013314. https:\/\/doi.org\/10.1007\/s00277-024-06119-7.","journal-title":"Ann Hematol"},{"issue":"14","key":"14718_CR27","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1111\/febs.15901","volume":"289","author":"YS Huoh","year":"2022","unstructured":"Huoh YS, Hur S. Death domain fold proteins in immune signaling and transcriptional regulation. FEBS J. 2022;289(14):4082\u201397. https:\/\/doi.org\/10.1111\/febs.15901.","journal-title":"FEBS J"},{"issue":"1","key":"14718_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41392-021-00678-1","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Zhang L, Dai T, Qin Z, Lu H, Zhang L, Zhou F. Liquid-liquid phase separation in human health and diseases. Signal Transduct Target Therapy. 2021;6(1):290. https:\/\/doi.org\/10.1038\/s41392-021-00678-1.","journal-title":"Signal Transduct Target Therapy"},{"issue":"8","key":"14718_CR29","first-page":"3766","volume":"11","author":"PH Peng","year":"2021","unstructured":"Peng PH, Hsu KW, Wu KJ. Liquid-liquid phase separation (LLPS) in cellular physiology and tumor biology. Am J Cancer Res. 2021;11(8):3766\u201376.","journal-title":"Am J Cancer Res"},{"issue":"4","key":"14718_CR30","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1073\/pnas.89.4.1403","volume":"89","author":"Y Takagaki","year":"1992","unstructured":"Takagaki Y, MacDonald CC, Shenk T, Manley JL. The human 64-kDa polyadenylylation factor contains a ribonucleoprotein-type RNA binding domain and unusual auxiliary motifs. Proc Natl Acad Sci USA. 1992;89(4):1403\u20137. https:\/\/doi.org\/10.1073\/pnas.89.4.1403.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3 Pt A","key":"14718_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.scr.2014.09.005","volume":"13","author":"BA Youngblood","year":"2014","unstructured":"Youngblood BA, MacDonald CC. CstF-64 is necessary for endoderm differentiation resulting in cardiomyocyte defects. Stem Cell Res. 2014;13(3 Pt A):413\u201321. https:\/\/doi.org\/10.1016\/j.scr.2014.09.005.","journal-title":"Stem Cell Res"},{"issue":"5","key":"14718_CR32","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/s0092-8674(00)82000-0","volume":"87","author":"Y Takagaki","year":"1996","unstructured":"Takagaki Y, Seipelt RL, Peterson ML, Manley JL. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell. 1996;87(5):941\u201352. https:\/\/doi.org\/10.1016\/s0092-8674(00)82000-0.","journal-title":"Cell"},{"issue":"20","key":"14718_CR33","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1158\/0008-5472.CAN-18-0822","volume":"78","author":"X Chen","year":"2018","unstructured":"Chen X, Zhang JX, Luo JH, Wu S, Yuan GJ, Ma NF, Feng Y, Cai MY, Chen RX, Lu J, Jiang LJ, Chen JW, Jin XH, Liu HL, Chen W, Guan XY, Kang TB, Zhou FJ, Xie D. CSTF2-Induced shortening of the RAC1 3\u2019UTR promotes the pathogenesis of urothelial carcinoma of the bladder. Cancer Res. 2018;78(20):5848\u201362. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0822.","journal-title":"Cancer Res"},{"issue":"22","key":"14718_CR34","doi-asserted-by":"publisher","first-page":"5638","DOI":"10.1158\/0008-5472.CAN-21-1201","volume":"81","author":"A Lin","year":"2021","unstructured":"Lin A, Ji P, Niu X, Zhao X, Chen Y, Liu W, Liu Y, Fan W, Sun Y, Miao C, Zhang S, Tan W, Lin D, Wagner EJ, Wu C. CstF64-Induced shortening of the BID 3\u2019UTR promotes esophageal squamous cell carcinoma progression by disrupting CeRNA Cross-talk with ZFP36L2. Cancer Res. 2021;81(22):5638\u201351. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1201.","journal-title":"Cancer Res"},{"key":"14718_CR35","doi-asserted-by":"publisher","first-page":"685980","DOI":"10.3389\/fonc.2021.685980","volume":"11","author":"Y Dong","year":"2021","unstructured":"Dong Y, Ma WM, Shi ZD, Zhang ZG, Zhou JH, Li Y, Zhang SQ, Pang K, Li BB, Zhang WD, Fan T, Zhu GY, Xue L, Li R, Liu Y, Hao L, Han CH. Role of NRP1 in bladder cancer pathogenesis and progression. Front Oncol. 2021;11:685980. https:\/\/doi.org\/10.3389\/fonc.2021.685980.","journal-title":"Front Oncol"},{"issue":"1","key":"14718_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3892\/or.2017.6089","volume":"39","author":"LE Jimenez-Hernandez","year":"2018","unstructured":"Jimenez-Hernandez LE, Vazquez-Santillan K, Castro-Oropeza R, Martinez-Ruiz G, Mu\u00f1oz-Galindo L, Gonzalez-Torres C, Cortes-Gonzalez CC, Victoria-Acosta G, Melendez-Zajgla J, Maldonado V. NRP1-positive lung cancer cells possess tumor-initiating properties. Oncol Rep. 2018;39(1):349\u201357. https:\/\/doi.org\/10.3892\/or.2017.6089.","journal-title":"Oncol Rep"},{"issue":"1\u20132","key":"14718_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10495-022-01784-3","volume":"28","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang L, Sun XL, Lu YC, Chen S, Pei DS, Zhang LS. NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer. Apoptosis: Int J Program Cell Death. 2023;28(1\u20132):233\u201346. https:\/\/doi.org\/10.1007\/s10495-022-01784-3.","journal-title":"Apoptosis: Int J Program Cell Death"},{"issue":"3","key":"14718_CR38","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ygyno.2007.02.005","volume":"105","author":"T Baba","year":"2007","unstructured":"Baba T, Kariya M, Higuchi T, Mandai M, Matsumura N, Kondoh E, Miyanishi M, Fukuhara K, Takakura K, Fujii S. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact Inhibition. Gynecol Oncol. 2007;105(3):703\u201311. https:\/\/doi.org\/10.1016\/j.ygyno.2007.02.005.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"14718_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000502861","volume":"4","author":"L van der Lely","year":"2019","unstructured":"van der Lely L, H\u00e4fliger J, Montalban-Arques A, B\u00e4bler K, Schwarzfischer M, Sabev M, Gottier C, Lang S, Scharl M, Spalinger MR. Loss of PTPN23 promotes proliferation and Epithelial-to-Mesenchymal transition in human intestinal cancer cells. Inflamm Intestinal Dis. 2019;4(4):161\u201373. https:\/\/doi.org\/10.1159\/000502861.","journal-title":"Inflamm Intestinal Dis"},{"issue":"2","key":"14718_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5732\/cjc.014.10146","volume":"34","author":"Y Du","year":"2015","unstructured":"Du Y, Grandis JR. Receptor-type protein tyrosine phosphatases in cancer. Chin J Cancer. 2015;34(2):61\u20139. https:\/\/doi.org\/10.5732\/cjc.014.10146.","journal-title":"Chin J Cancer"},{"issue":"3","key":"14718_CR41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/15548627.2023.2259775","volume":"20","author":"SK Yeo","year":"2024","unstructured":"Yeo SK, Haas M, Manupati K, Hao M, Yang F, Chen S, Guan JL. AZI2 mediates TBK1 activation at unresolved selective autophagy cargo receptor complexes with implications for CD8 T-cell infiltration in breast cancer. Autophagy. 2024;20(3):525\u201340. https:\/\/doi.org\/10.1080\/15548627.2023.2259775.","journal-title":"Autophagy"},{"issue":"1","key":"14718_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/jhg.2010.147","volume":"56","author":"Y Sun","year":"2011","unstructured":"Sun Y, Chen J, Sun H, Cheng J, Li J, Lu Y, Lu Y, Jin Z, Zhu Y, Ouyang X, Yan D, Dai P, Han D, Yang W, Wang R, Liu X, Yuan H. Novel missense mutations in MYO7A underlying postlingual high- or low-frequency non-syndromic hearing impairment in two large families from China. J Hum Genet. 2011;56(1):64\u201370. https:\/\/doi.org\/10.1038\/jhg.2010.147.","journal-title":"J Hum Genet"},{"key":"14718_CR43","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.omtm.2023.08.012","volume":"30","author":"SC Lau","year":"2023","unstructured":"Lau SC, Grati M, Isgrig K, Sinan M, Calabro KR, Zhu J, Ishibashi Y, Ozgur Z, Wafa T, Belyantseva IA, Fitzgerald T, Friedman TB, Boye SL, Boye SE, Chien WW. Dual-AAV vector-mediated expression of MYO7A improves vestibular function in a mouse model of Usher syndrome 1B. Molecular therapy. Methods Clin Dev. 2023;30:534\u201345. https:\/\/doi.org\/10.1016\/j.omtm.2023.08.012.","journal-title":"Methods Clin Dev"},{"issue":"4","key":"14718_CR44","doi-asserted-by":"publisher","first-page":"jcs209924","DOI":"10.1242\/jcs.209924","volume":"131","author":"Y Liu","year":"2018","unstructured":"Liu Y, Wei X, Guan L, Xu S, Yuan Y, Lv D, He X, Zhan J, Kong Y, Guo J, Zhang H. Unconventional myosin VIIA promotes melanoma progression. J Cell Sci. 2018;131(4):jcs209924. https:\/\/doi.org\/10.1242\/jcs.209924.","journal-title":"J Cell Sci"},{"key":"14718_CR45","doi-asserted-by":"publisher","first-page":"102176","DOI":"10.1016\/j.ceb.2023.102176","volume":"82","author":"J Dabin","year":"2023","unstructured":"Dabin J, Mori M, Polo SE. The DNA damage response in the chromatin context: A coordinated process. Curr Opin Cell Biol. 2023;82:102176. https:\/\/doi.org\/10.1016\/j.ceb.2023.102176.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"14718_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/cr.2007.115","volume":"18","author":"GM Li","year":"2008","unstructured":"Li GM. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008;18(1):85\u201398. https:\/\/doi.org\/10.1038\/cr.2007.115.","journal-title":"Cell Res"},{"key":"14718_CR47","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fmolb.2020.00122","volume":"7","author":"N Pe\u0107ina-\u0160laus","year":"2020","unstructured":"Pe\u0107ina-\u0160laus N, Kafka A, Salamon I, Bukovac A. Mismatch repair pathway, genome stability and cancer. Front Mol Biosci. 2020;7:122. https:\/\/doi.org\/10.3389\/fmolb.2020.00122.","journal-title":"Front Mol Biosci"},{"key":"14718_CR48","doi-asserted-by":"publisher","first-page":"111824","DOI":"10.1016\/j.biopha.2021.111824","volume":"141","author":"M Ashrafizadeh","year":"2021","unstructured":"Ashrafizadeh M, Mirzaei S, Hashemi F, Zarrabi A, Zabolian A, Saleki H, Sharifzadeh SO, Soleymani L, Daneshi S, Hushmandi K, Khan H, Kumar AP, Aref AR, Samarghandian S. New insight towards development of Paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomed Pharmacother. 2021;141:111824. https:\/\/doi.org\/10.1016\/j.biopha.2021.111824.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"14718_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/sj.leu.2400557","volume":"11","author":"Y Huang","year":"1997","unstructured":"Huang Y, Ibrado AM, Reed JC, Bullock G, Ray S, Tang C, Bhalla K. Co-expression of several molecular mechanisms of multidrug resistance and their significance for Paclitaxel cytotoxicity in human AML HL-60 cells. Leukemia. 1997;11(2):253\u20137. https:\/\/doi.org\/10.1038\/sj.leu.2400557.","journal-title":"Leukemia"},{"issue":"1","key":"14718_CR50","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41419-025-07427-0","volume":"16","author":"H Wang","year":"2025","unstructured":"Wang H, Chen Y, Yang Y, Song R, Gu S, Cao X, Zhang L, Yang Y, Hou T, Qi X, Yang Y, Wang Y, Bai T, Feng D, Yang X, He J. MAGI3 enhances sensitivity to Sunitinib in renal cell carcinoma by suppressing the MAS\/ERK axis and serves as a prognostic marker. Cell Death Dis. 2025;16(1):102. https:\/\/doi.org\/10.1038\/s41419-025-07427-0.","journal-title":"Cell Death Dis"},{"issue":"5","key":"14718_CR51","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/bjh.13353","volume":"169","author":"W Fiedler","year":"2015","unstructured":"Fiedler W, Kayser S, Kebenko M, Janning M, Krauter J, Schittenhelm M, G\u00f6tze K, Weber D, G\u00f6hring G, Teleanu V, Thol F, Heuser M, D\u00f6hner K, Ganser A, D\u00f6hner H, Schlenk RF. A phase I\/II study of Sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations. Br J Haematol. 2015;169(5):694\u2013700. https:\/\/doi.org\/10.1111\/bjh.13353.","journal-title":"Br J Haematol"},{"issue":"7","key":"14718_CR52","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1055\/a-2088-3718","volume":"73","author":"N Omidkhoda","year":"2023","unstructured":"Omidkhoda N, Mahdiani S, Samadi S, Rahimi H, Mohammadpour AH. Efficacy and safety of valproic acid in myelodysplastic syndrome and acute myeloid leukemia; a narrative review. Drug Res (Stuttg). 2023;73(7):378\u201387. https:\/\/doi.org\/10.1055\/a-2088-3718.","journal-title":"Drug Res (Stuttg)"},{"issue":"7","key":"14718_CR53","doi-asserted-by":"publisher","first-page":"8105","DOI":"10.18632\/oncotarget.6991","volume":"7","author":"C Leitch","year":"2016","unstructured":"Leitch C, Osdal T, Andresen V, Molland M, Kristiansen S, Nguyen XN, Bruserud \u00d8, Gjertsen BT, McCormack E. Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia. Oncotarget. 2016;7(7):8105\u201318. https:\/\/doi.org\/10.18632\/oncotarget.6991.","journal-title":"Oncotarget"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14718-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14718-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14718-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T18:03:16Z","timestamp":1755540196000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14718-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14718"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14718-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not needed because this is a meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1326"}}